FDA Approves Bevacizumab for Second-Line Combinations

Bevacizumab is now approved by the Food and Drug Administration for use in combination with fluoropyrimidine-irinotecan-based or fluoropyrimidine-oxaliplatin-based chemotherapy for metastatic colorectal...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news